Dr. Lesinski is an Assistant Professor in The Department of Internal Medicine, Division of Medical Oncology at The Ohio State University. Dr. Lesinski received his Ph.D. in 2001 from The Medical College of Ohio in Toledo, OH and an MPH from The Ohio State University in 2012. Dr. Lesinski trained as a post-doctoral fellow at The Ohio State University from 2001 – 2005 and joined the faculty in 2005 as a Research Assistant Professor in the Department of Molecular Virology, Immunology and Medical Genetics. In 2008, Dr. Lesinski was recruited to the Division of Medical Oncology as a Tenure-Track Assistant Professor. Dr. Lesinski’s research is focused on gaining a greater understanding of the interactions between the host immune system and tumor cells with an emphasis on signal transduction. The ultimate goal is to use this knowledge to develop novel therapeutic or chemo-preventative approaches to help patients with cancer, and improve upon existing therapies. Dr. Lesinski has authored more than 40 publications or book chapters in the area of basic science and translational research on solid tumor oncology, immunotherapy and clinical trials. Dr. Lesinski has received funding from The National Institutes of Health, The Melanoma Research Foundation, The Valvano Foundation for Cancer Research, and The Harry J. Lloyd Charitable Trust for his research on melanoma and from The Ohio Soybean Council to investigate the immune modulating effects of dietary soy. He holds professional memberships through The American Association for Cancer Research, The Society for Biologic Therapy of Cancer and The Society for Melanoma Research. Dr. Lesinski has numerous active collaborations with clinical and basic science investigators at Ohio State focused on development of novel small molecule inhibitors and modulating immune function for cancer therapy and prevention.
Biography Updated on 16 October 2012